• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

兔热病的组织学和分子诊断:一种北美特有的潜在生物恐怖主义病原体。

Histologic and molecular diagnosis of tularemia: a potential bioterrorism agent endemic to North America.

作者信息

Lamps Laura W, Havens Jennifer M, Sjostedt Anders, Page David L, Scott Margie A

机构信息

Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.

出版信息

Mod Pathol. 2004 May;17(5):489-95. doi: 10.1038/modpathol.3800087.

DOI:10.1038/modpathol.3800087
PMID:15001997
Abstract

Francisella tularensis (FT), a zoonotic bacterium that causes tularemia, has received attention as a possible bioterrorism threat. We developed a PCR assay for use in fixed, processed tissues, which are safer to handle and allow archival testing. PCR analysis for a 211-bp fragment of the FT lipoprotein gene was performed on tissues from 16 cases of tularemia. In all, 14/15 cases with intact DNA (93%) were positive for FT by PCR. Frequent histologic findings in PCR-positive tissues included irregular microabscesses and granulomas in liver, spleen, kidney, and lymph nodes, and necrotizing pneumonia. Unusual cases featuring suppurative leptomeningitis and gastrointestinal ulcers were also seen. As this disease is endemic in North America, and has been identified as a potential bioterroristic threat, awareness of the clinicopathologic spectrum of disease and available detection methods is increasingly important. This PCR assay, the first designed for use in processed tissues, is an excellent method for diagnosis of tularemia.

摘要

土拉弗朗西斯菌(FT)是一种可导致兔热病的人畜共患细菌,因其可能构成生物恐怖主义威胁而受到关注。我们开发了一种用于固定、处理过的组织的PCR检测方法,这种组织更易于处理且可进行存档检测。对16例兔热病病例的组织进行了FT脂蛋白基因211bp片段的PCR分析。总体而言,15例DNA完整的病例中有14例(93%)通过PCR检测FT呈阳性。PCR阳性组织中常见的组织学表现包括肝脏、脾脏、肾脏和淋巴结中的不规则微脓肿和肉芽肿,以及坏死性肺炎。还发现了以化脓性软脑膜炎和胃肠道溃疡为特征的罕见病例。由于这种疾病在北美为地方性疾病,且已被确定为潜在的生物恐怖主义威胁,了解该疾病的临床病理谱和可用的检测方法变得越来越重要。这种PCR检测方法是首个设计用于处理过的组织的方法,是诊断兔热病的一种优秀方法。

相似文献

1
Histologic and molecular diagnosis of tularemia: a potential bioterrorism agent endemic to North America.兔热病的组织学和分子诊断:一种北美特有的潜在生物恐怖主义病原体。
Mod Pathol. 2004 May;17(5):489-95. doi: 10.1038/modpathol.3800087.
2
[Evaluation of a newly-developed ready-to-use commercial PCR kit for the molecular diagnosis of Francisella tularensis].[一种新开发的即用型商业PCR试剂盒用于土拉弗朗西斯菌分子诊断的评估]
Mikrobiyol Bul. 2014 Jan;48(1):135-42.
3
Rapid laboratory diagnosis of ulceroglandular tularemia with polymerase chain reaction.用聚合酶链反应对溃疡腺型土拉菌病进行快速实验室诊断。
Scand J Infect Dis. 2001;33(5):383-5. doi: 10.1080/003655401750174101.
4
Preclinical testing of a vaccine candidate against tularemia.一种抗土拉菌病候选疫苗的临床前测试。
PLoS One. 2015 Apr 21;10(4):e0124326. doi: 10.1371/journal.pone.0124326. eCollection 2015.
5
Emergence of tularemia in France: paradigm of the Burgundy region.法国出现兔热病:以勃艮第地区为例。
Int J Infect Dis. 2011 Dec;15(12):e882-3. doi: 10.1016/j.ijid.2011.08.007. Epub 2011 Oct 4.
6
The Genetic Diversity and Evolution of Francisella tularensis with Comments on Detection by PCR.土拉弗朗西斯菌的遗传多样性与进化及PCR检测评述
Curr Issues Mol Biol. 2016;18:79-91. Epub 2015 Sep 3.
7
Pathogenesis of tularemia in monkeys aerogenically exposed to Francisella tularensis 425.经空气暴露于土拉热弗朗西斯菌425的猴子中土拉菌病的发病机制
Infect Immun. 1972 May;5(5):734-44. doi: 10.1128/iai.5.5.734-744.1972.
8
[Experimental inhalation tularemia].[实验性吸入性兔热病]
Zh Mikrobiol Epidemiol Immunobiol. 1966 Sep;43(9):62-6.
9
[An oropharyngeal tularemia case diagnosed by the isolation of Francisella tularensis on human blood agar].[通过在人血琼脂上分离土拉弗朗西斯菌诊断的一例口咽型兔热病病例]
Mikrobiyol Bul. 2010 Oct;44(4):657-63.
10
Coinfections identified from metagenomic analysis of cervical lymph nodes from tularemia patients.从土拉热患者的颈淋巴结宏基因组分析中鉴定出的合并感染。
BMC Infect Dis. 2018 Jul 11;18(1):319. doi: 10.1186/s12879-018-3218-2.

引用本文的文献

1
Development of a novel sandwich immunoassay based on targeting recombinant Francisella outer membrane protein A for the diagnosis of tularemia.基于靶向重组弗朗西斯氏菌外膜蛋白 A 的新型夹心免疫分析法的土拉菌病诊断。
Front Cell Infect Microbiol. 2024 Aug 20;14:1455259. doi: 10.3389/fcimb.2024.1455259. eCollection 2024.
2
Marmosets as models of infectious diseases.狨猴作为传染病模型。
Front Cell Infect Microbiol. 2024 Feb 23;14:1340017. doi: 10.3389/fcimb.2024.1340017. eCollection 2024.
3
A new multiplexed magnetic capture-Droplet digital PCR tool for monitoring wildlife population health and pathogen surveillance.
一种用于监测野生动物种群健康和病原体监测的新型多重磁捕获-液滴数字PCR工具。
Ecol Evol. 2023 Oct 31;13(11):e10655. doi: 10.1002/ece3.10655. eCollection 2023 Nov.
4
Identification of Putative Bacterial Pathogens for Orofacial Granulomatosis Based on 16S rRNA Metagenomic Analysis.基于 16S rRNA 宏基因组分析鉴定口腔颌面部肉芽肿病的潜在细菌病原体。
Microbiol Spectr. 2023 Jun 15;11(3):e0226622. doi: 10.1128/spectrum.02266-22. Epub 2023 May 25.
5
Offense and Defense in Granulomatous Inflammation Disease.肉芽肿性炎症疾病中的攻击与防御
Front Cell Infect Microbiol. 2022 Jun 29;12:797749. doi: 10.3389/fcimb.2022.797749. eCollection 2022.
6
Primary Lymphocutaneous in an Immunocompetent Host: Case Report and Literature Review.原发性皮肤黏膜淋球菌感染 1 例报告并文献复习。
Medicina (Kaunas). 2022 Mar 28;58(4):488. doi: 10.3390/medicina58040488.
7
Development of a novel multiepitope chimeric vaccine against anthrax.开发一种针对炭疽病的新型多表位嵌合疫苗。
Med Microbiol Immunol. 2019 Apr;208(2):185-195. doi: 10.1007/s00430-019-00577-x. Epub 2019 Jan 22.
8
Adaptive Immunity to and Considerations for Vaccine Development.适应性免疫与疫苗开发的考虑因素。
Front Cell Infect Microbiol. 2018 Apr 6;8:115. doi: 10.3389/fcimb.2018.00115. eCollection 2018.
9
The Cynomolgus Macaque Natural History Model of Pneumonic Tularemia for Predicting Clinical Efficacy Under the Animal Rule.豚鼠耳炎自然史模型预测动物规则下临床疗效的研究。
Front Cell Infect Microbiol. 2018 Apr 4;8:99. doi: 10.3389/fcimb.2018.00099. eCollection 2018.
10
Treatment-failure tularemia in children.儿童兔热病治疗失败
Korean J Pediatr. 2018 Feb;61(2):49-52. doi: 10.3345/kjp.2018.61.2.49. Epub 2018 Feb 28.